| Home - NervGen Pharma |
| https://nervgen.com Direct contact link NervGen (TSX-V: NGEN OTCQX: NGENF) is a clinical stage biotech company dedicated to developing innovative treatments that enable the nervous system to repair itself following damage whether due to injury or disease. NervGen’s lead drug candidate NVG-291 is being evaluated in a Phase 1b/2a clinical trial. The company’s lead target indication is spinal cord injury. […]  in**@nervgen.com /nervgen /channel/ucak7awwvzkhkrenrobsjx0aTelephone: (778) 731-1711;;(6****************** |  |
This company may appear in the following contact lists::
| NervGen Pharma | Nervous System |
| Nervous System | System Repair |
For a limited time, sign up to our Starter Plan for $4.99 a month to unhide all information about the company.